March 24, 2015—Members of a House health subcommittee expressed strong support for the 340B program during a hearing today, with some stating more should be done to clarify program requirements and enhance program transparency.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)